← Back to Search

Qigong for Post-COVID Syndrome

N/A
Recruiting
Research Sponsored by University of California, Davis
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Willing and able to travel to the qigong sessions to participate in person in Sacramento, CA.
English-speaking adults age 18 or greater
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 weeks
Awards & highlights

Study Summary

This trial will test if qigong can help improve health and quality of life for long-term COVID-19 symptom sufferers.

Who is the study for?
This trial is for English-speaking adults over 18 who had COVID-19 and are still feeling sick after 12 weeks. They must be able to use the internet, fill out forms, and travel to Sacramento, CA for qigong sessions. People with lung damage from COVID-19, dementia or other conditions that make it hard to participate fully can't join.Check my eligibility
What is being tested?
The study is testing if external qigong can improve life quality for people with long-term symptoms from COVID-19. Participants will attend qigong sessions in person and their health changes will be tracked through questionnaires.See study design
What are the potential side effects?
Since this trial involves a non-invasive practice like qigong, which includes gentle movements and meditation, no significant side effects are expected. However, individual experiences may vary.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I can travel to Sacramento, CA for qigong sessions.
Select...
I am 18 or older and speak English.
Select...
I have had COVID-19 symptoms for more than 12 weeks.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 8 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in physical health

Trial Design

2Treatment groups
Experimental Treatment
Group I: Waitlist ControlExperimental Treatment1 Intervention
Receives 6 sessions of qigong after the immediate group
Group II: ImmediateExperimental Treatment1 Intervention
Receives 6 sessions of qigong first.

Find a Location

Who is running the clinical trial?

University of California, DavisLead Sponsor
909 Previous Clinical Trials
4,704,082 Total Patients Enrolled
8 Trials studying COVID-19
7,293 Patients Enrolled for COVID-19

Media Library

External Qigong Clinical Trial Eligibility Overview. Trial Name: NCT05675995 — N/A
COVID-19 Research Study Groups: Immediate, Waitlist Control
COVID-19 Clinical Trial 2023: External Qigong Highlights & Side Effects. Trial Name: NCT05675995 — N/A
External Qigong 2023 Treatment Timeline for Medical Study. Trial Name: NCT05675995 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Approximately how many volunteers are enrolled in this research trial?

"Affirmative, the information hosted on clinicaltrials.gov attests that this experiment is presently seeking suitable candidates. It was originally put forward on April 1st 2023 and last updated accordingly. 48 individuals need to be identified from one establishment for enrolment in the trial."

Answered by AI

Are there any open opportunities to participate in this clinical trial?

"Affirmative. Clinicaltrials.gov provides evidence that this medical experiment, which was initially released on April 1st 2023, is presently recruiting. The trial requires 48 participants to be sourced from one location."

Answered by AI
~22 spots leftby Mar 2025